Balyasny Asset Management LLC Astrazeneca PLC Put Options Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $728,365 - $832,390	9,500 New	9,500 $740,000
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $6.48 Million - $7.49 Million	-137,500 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $37 Million - $44.2 Million	-762,500 Reduced 84.72%	137,500 $6.87 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $30.4 Million - $36.9 Million	857,000 Added 1993.02%	900,000 $36.4 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $1.42 Million - $1.58 Million	43,000 New	43,000 $1.5 Million

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.